These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11753757)
1. The antihyperglycemic effect of estrone sulfate in genetically obese-diabetic (ob/ob) mice is associated with reduced hepatic glucose-6-phosphatase. Borthwick EB; Houston MP; Coughtrie MW; Burchell A Horm Metab Res; 2001 Dec; 33(12):721-6. PubMed ID: 11753757 [TBL] [Abstract][Full Text] [Related]
2. Hepatic drug metabolism and the activities of NADPH generating enzymes and glucose-6-phosphatase in phenobarbital treated genetically obese (ob/ob) mice. Stengard JH; Saarni HU; Karvonen RI; Lahtela JT; Kärki NT; Stenbäck F; Sotaniemi EA Biomed Pharmacother; 1987; 41(7):389-96. PubMed ID: 2833324 [TBL] [Abstract][Full Text] [Related]
3. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus. Karvonen I; Stengård JH; Huupponen R; Stenbäck FG; Sotaniemi EA Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061 [TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle. Kaidanovich-Beilin O; Eldar-Finkelman H J Pharmacol Exp Ther; 2006 Jan; 316(1):17-24. PubMed ID: 16169938 [TBL] [Abstract][Full Text] [Related]
5. The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice. Vicario PP; Slater EE; Saperstein R Biochem Int; 1989 Sep; 19(3):553-61. PubMed ID: 2510726 [TBL] [Abstract][Full Text] [Related]
7. Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Enriquez A; Leclercq I; Farrell GC; Robertson G Biochem Biophys Res Commun; 1999 Feb; 255(2):300-6. PubMed ID: 10049703 [TBL] [Abstract][Full Text] [Related]
8. Enzyme activities of hepatic glucose utilization in the fed and fasting genetically obese mouse at 4-5 months of age. Hron WT; Sobocinski KA; Menahan LA Horm Metab Res; 1984 Dec; 16 Suppl 1():32-6. PubMed ID: 6241916 [TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice. Steerenberg PA; Beekhof PK; Feskens EJ; Lips CJ; Höppener JW; Beems RB Diabetes Nutr Metab; 2002 Aug; 15(4):205-14. PubMed ID: 12416657 [TBL] [Abstract][Full Text] [Related]
11. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568 [TBL] [Abstract][Full Text] [Related]
12. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats. Pari L; Saravanan R Diabetes Obes Metab; 2004 Jul; 6(4):286-92. PubMed ID: 15171753 [TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice. Liang Y; Osborne MC; Monia BP; Bhanot S; Watts LM; She P; DeCarlo SO; Chen X; Demarest K Metabolism; 2005 Jul; 54(7):848-55. PubMed ID: 15988691 [TBL] [Abstract][Full Text] [Related]
15. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance. Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727 [TBL] [Abstract][Full Text] [Related]
16. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Choi MS; Jung UJ; Yeo J; Kim MJ; Lee MK Diabetes Metab Res Rev; 2008; 24(1):74-81. PubMed ID: 17932873 [TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of short-term fasting in obese hyperglycaemic humans and mice. Belfiore F; Iannello S; Rabuazzo AM; Campione R Int J Obes; 1987; 11(6):631-40. PubMed ID: 2831163 [TBL] [Abstract][Full Text] [Related]
18. Regulation of pathways of glucose metabolism in the kidney. The activity of the pentose phosphate pathway, glycolytic route and the regulation of phosphofructokinase in the kidney of lean and genetically obese (ob/ob) mice; comparison with effects of diabetes. Sochor M; Kunjara S; McLean P Horm Metab Res; 1988 Nov; 20(11):676-81. PubMed ID: 2975263 [TBL] [Abstract][Full Text] [Related]
19. Steroid sulphates inhibit the rat hepatic microsomal glucose-6-phosphatase system. Scott HM; Coughtrie MW; Burchell A Biochem Pharmacol; 1991 May; 41(10):1529-32. PubMed ID: 1850279 [No Abstract] [Full Text] [Related]
20. Anti-hyperglycemic effect of Potentilla discolor decoction on obese-diabetic (Ob-db) mice and its chemical composition. Song C; Huang L; Rong L; Zhou Z; Peng X; Yu S; Fang N Fitoterapia; 2012 Dec; 83(8):1474-83. PubMed ID: 22960384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]